A Supreme Court decision in June to strike down a company’s patent on genes linked to breast cancer could have far-reaching consequences for biotechnology and medical research.
In a rare unanimous decision, the justices ruled that naturally occurring genes may not be patented.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.